Mercury Pharmaceuticals

We are de-risking biomedical innovations, while turning biomedical knowledge into social and economic value.

Stay Informed!

Access barriers keep Black and low-income patients out of genetics clinics

19

Dec 2025

Access barriers keep Black and low-income patients out of genetics clinics

Black patients and patients from socioeconomically disadvantaged neighborhoods are dramatically under-represented in genetics clinics-often at rates half or less than those of White patients or individuals from wealthier areas-according to researchers at the Perelman School of Medicine at the University of Pennsylvania and Massachusetts General Hospital.

FDA warns against fake treatments for infertility

19

Dec 2025

FDA warns against fake treatments for infertility

You may know someone who has been unable to get pregnant due to infertility issues. According to the Centers for Disease Control and Prevention, about 12 percent of women aged 15 to 44 in the United States have difficulty becoming pregnant or carrying a pregnancy to term.

AI-driven skilling linked to lower burnout and greater worker autonomy

19

Dec 2025

AI-driven skilling linked to lower burnout and greater worker autonomy

University of Phoenix College of Doctoral Studies announced the publication of "Burnout and Autonomy in the Modern Workforce: The Role of AI-Driven Skilling in Equity and Resilience," a new white paper by Rheanna Reed, D.M., which draws on five years of University of Phoenix Career Optimism Index data, to examine how burnout, autonomy, equity and artificial intelligence (AI) intersect in the U.S. workforce and outlines strategies employers can use to build a more resilient, future-ready workforce.

MERCURY trials

Clinical trials are very important as it allow us to evaluate the effectiveness of new drugs, new devices, preventative strategies or treatment strategies. It also enables us to discover better ways for patients' care.
- Learn more

Cancer

Our mission remains constant as we endeavor to deliver novel medicines to patients with cancer, treating solid tumors with high unmet medical needs in well-defined patient populations that are currently not well supported.
- Learn more

Neuroscience

Whether you're looking to manufacture toxicology batches or cGMP material for clinical trials, we can help you expedite molecules to clinic with full transparency.
- Learn more

Mercury Pharmaceuticals

Why Us?

Strong experience in academic research and technology transfer makes us understand your goals and motivations as a technology originator.
Our experience in drug development from discovery to clinical and commercial stages makes us an insider player within the biopharmaceutical industry.
Smart approach to project management that helps speed up development stages and decision making.
Availability of own investment up to 2m€ per project allows us to reach the next value milestone.